GHC — Garofalo Health Care SpA Income Statement
0.000.00%
- €459.14m
- €667.25m
- €462.18m
- 83
- 34
- 71
- 71
Annual income statement for Garofalo Health Care SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 207 | 278 | 315 | 361 | 462 |
Cost of Revenue | |||||
Gross Profit | 95.5 | 126 | 143 | 164 | 211 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 191 | 250 | 283 | 322 | 418 |
Operating Profit | 15.5 | 28.2 | 31.7 | 39.2 | 44.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13 | 24 | 27.4 | 28.9 | 30.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.8 | 18.8 | 21.4 | 20.9 | 21.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11.8 | 18.8 | 21.4 | 20.8 | 21.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.8 | 18.8 | 21.4 | 20.8 | 21.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.14 | 0.245 | 0.289 | 0.257 | 0.256 |
Dividends per Share |